Recombinant multi-species GP73/GOLPH2/GOLM1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GP73/GOLPH2/GOLM1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The Golgi complex plays a key role in the sorting and modification of proteins exported from the endoplasmic reticulum. The protein encoded by this gene is a type II Golgi transmembrane protein. It processes proteins synthesized in the rough endoplasmic reticulum and assists in the transport of protein cargo through the Golgi apparatus. The expression of this gene has been observed to be upregulated in response to viral infection. Alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Sep 2009]
The Alternative Names of target: 2310001L02Rik,C9orf155,D030064E01Rik,GOLM1,GOLPH2,GP73,Golgi membrane protein 1,Golgi membrane protein GP73,Golgi phosphoprotein 2,Golm1,Golph2,HEL46,PSEC0257,bA379P1.3

Target products collectionGo to GP73/GOLPH2/GOLM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IO052-Ag-1/ GM-Tg-hg-IO052-Ag-2 Human GP73/GOLPH2/GOLM1 protein Human
GM-Tg-rg-IO052-Ag-1/ GM-Tg-rg-IO052-Ag-2 Rat GP73/GOLPH2/GOLM1 protein Rat
GM-Tg-mg-IO052-Ag-1/ GM-Tg-mg-IO052-Ag-2 Mouse GP73/GOLPH2/GOLM1 protein Mouse
GM-Tg-cynog-IO052-Ag-1/ GM-Tg-cynog-IO052-Ag-2 Cynomolgus/Rhesus macaque GP73/GOLPH2/GOLM1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IO052-Ag-1/ GM-Tg-felg-IO052-Ag-2 Feline GP73/GOLPH2/GOLM1 protein Feline
GM-Tg-cang-IO052-Ag-1/ GM-Tg-cang-IO052-Ag-2 Canine GP73/GOLPH2/GOLM1 protein Canine
GM-Tg-bovg-IO052-Ag-1/ GM-Tg-bovg-IO052-Ag-2 Bovine GP73/GOLPH2/GOLM1 protein Bovine
GM-Tg-equg-IO052-Ag-1/ GM-Tg-equg-IO052-Ag-2 Equine GP73/GOLPH2/GOLM1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IO052-Ag-1/ GM-Tg-hg-IO052-Ag-2; GM-Tg-rg-IO052-Ag-1/ GM-Tg-rg-IO052-Ag-2;
GM-Tg-mg-IO052-Ag-1/ GM-Tg-mg-IO052-Ag-2; GM-Tg-cynog-IO052-Ag-1/ GM-Tg-cynog-IO052-Ag-2;
GM-Tg-felg-IO052-Ag-1/ GM-Tg-felg-IO052-Ag-2; GM-Tg-cang-IO052-Ag-1/ GM-Tg-cang-IO052-Ag-2;
GM-Tg-bovg-IO052-Ag-1/ GM-Tg-bovg-IO052-Ag-2; GM-Tg-equg-IO052-Ag-1/ GM-Tg-equg-IO052-Ag-2
Products Name GP73/GOLPH2/GOLM1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GP73/GOLPH2/GOLM1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GP73/GOLPH2/GOLM1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.